[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  stefan katafai [@SKatafai](/creator/twitter/SKatafai) on x XXX followers Created: 2025-07-24 14:53:46 UTC Immunoprecise Antibodies ( $IPA) $XXXXXX +0.3550 (+19.51%) predicts ADA risk in hours, cutting biologic failures (40% late-stage, $1–2B cost). 250–300% upside (target $2.83–$3.24). Insider buying: 763K shares ($306K, Q3 FY25). Q2 earnings Aug 6–8. Buy for biotech/AI!  XXX engagements  **Related Topics** [coins ai](/topic/coins-ai) [$306k](/topic/$306k) [stocks](/topic/stocks) [insider](/topic/insider) [$12b](/topic/$12b) [$ipa](/topic/$ipa) [Post Link](https://x.com/SKatafai/status/1948396191684653427)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
stefan katafai @SKatafai on x XXX followers
Created: 2025-07-24 14:53:46 UTC
Immunoprecise Antibodies ( $IPA) $XXXXXX +0.3550 (+19.51%) predicts ADA risk in hours, cutting biologic failures (40% late-stage, $1–2B cost). 250–300% upside (target $2.83–$3.24).
Insider buying: 763K shares ($306K, Q3 FY25).
Q2 earnings Aug 6–8. Buy for biotech/AI!
XXX engagements
/post/tweet::1948396191684653427